Low-dose intravenous immunoglobulin therapy for intractable dermatomyositis skin lesions.
We report a 45-year-old female patient with dermatomyositis whose corticosteroid-resistant cutaneous manifestations improved with low-dose (0.1 g/kg body weight/day for 5 days weekly for 2 weeks) intravenous immunoglobulin (IVIG) therapy.